Skip to main content
Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Last trade price

Orchard Therapeutics Revenue

Orchard Therapeutics had revenue of $21.84M in the twelve months ending September 30, 2023, with 35.21% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $6.30M with 9.09% year-over-year growth. In the year 2022, Orchard Therapeutics had annual revenue of $22.66M with 1,252.54% growth.

Revenue (ttm)
$21.84M
Revenue Growth
+35.21%
P/S Ratio
34.65
Revenue / Employee
$131,560
Employees
166
Market Cap
756.82M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202222.66M20.98M1,252.54%
Dec 31, 20211.68M-920.00K-35.45%
Dec 31, 20202.60M82.00K3.26%
Dec 31, 20192.51M437.00K21.05%
Dec 31, 20182.08M--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ORTX News

More News